Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy

Volume
29
Pagination
903 - 910
DOI
10.1097/QAD.0000000000000623
Journal
AIDS
Issue
8
ISSN
0269-9370
Metadata
Show full item record
Authors
Alwan, F; He, A; Montoto, S; Kassam, S; Mee, M; Burns, F; Edwards, S; Wilson, A; Tenant-Flowers, M; Marcus, R
URI
http://qmro.qmul.ac.uk/xmlui/handle/123456789/6979
Collections